Mercados españoles cerrados

Vaxxinity, Inc. (VAXX)

OTC Markets OTCPK - OTC Markets OTCPK Precio demorado. Divisa en USD
Añadir a la lista de favoritos
0,3000+0,0505 (+20,24%)
Al cierre: 03:59PM EDT

Transacciones de accionistas miembros de la empresa

Divisa en USD
Compras de personas con información privilegiada de los 6 últimos mesesAccionesTrans
Compras00
VentasN/A0
Cuotas netas adquiridas (vendidas)00
Acciones de persona con información privilegiada totales64,27MN/A
% de acciones netas adquiridas (vendidas)N/AN/A
Compras institucionales netas del trimestre anterior al último trimestreAcciones
Cuotas netas adquiridas (vendidas)N/A
% de cambio en la posesión de acciones institucionalesN/A

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

Persona con información privilegiadaTransacciónTipoValorFechaAcciones

PRIME MOVERS LAB FUND I LP
Beneficial Owner of more than 10% of a Class of Security

Sale at price 1.67 - 1.88 per share.Indirecto168.58808 sept 202396.936

DIAMANDIS PETER
Director

Conversion of Exercise of derivative security at price 0.57 - 1.21 per share.Directo300.81626 abr 2023475.537

PRIME MOVERS LAB FUND I LP
Beneficial Owner of more than 10% of a Class of Security

Sale at price 3.35 per share.Indirecto1.678.01923 ene 2023500.692

PRIME MOVERS LAB FUND I LP
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.04 - 2.38 per share.Indirecto824.87202 dic 2022348.548

PRIME MOVERS LAB LLC
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.40 per share.Indirecto89.76806 sept 202237.358

PRIME MOVERS LAB FUND I LP
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.40 per share.Indirecto89.76806 sept 202237.358

PRIME MOVERS LAB LLC
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.33 - 2.45 per share.Indirecto496.72725 ago 2022207.680

PRIME MOVERS LAB FUND I LP
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.33 - 2.45 per share.Indirecto496.72725 ago 2022207.680

GUIRAKHOO FARSHAD
Officer

Conversion of Exercise of derivative security at price 0.57 per share.Directo33.42822 ago 202258.645

REESE LOU
Officer, Director and Beneficial Owner

Purchase at price 1.99 per share.Indirecto199.29016 jun 2022100.000

HU MEI MEI
Chief Executive Officer

Purchase at price 1.99 per share.Indirecto199.29016 jun 2022100.000

UNITED BIOMEDICAL, INC.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 1.99 per share.Directo199.29016 jun 2022100.000

PRIME MOVERS LAB LLC
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.43 - 2.80 per share.Indirecto449.86813 jun 2022179.000

PRIME MOVERS LAB FUND I LP
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.43 - 2.80 per share.Indirecto449.86813 jun 2022179.000

REESE LOU
Officer, Director and Beneficial Owner

Purchase at price 2.72 - 2.95 per share.Indirecto59.38609 jun 202220.978

HU MEI MEI
Chief Executive Officer

Purchase at price 2.72 - 2.95 per share.Indirecto59.38609 jun 202220.978

UNITED BIOMEDICAL, INC.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 2.72 - 2.95 per share.Directo59.38609 jun 202220.978

GUIRAKHOO FARSHAD
Officer

Conversion of Exercise of derivative security at price 0.57 per share.Directo5.70003 may 202210.000

REESE LOU
Officer and Director

Purchase at price 3.45 - 3.58 per share.Indirecto79.68927 abr 202222.912

HU MEI MEI
Chief Executive Officer

Purchase at price 3.45 - 3.58 per share.Indirecto79.68927 abr 202222.912

UNITED BIOMEDICAL, INC.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 3.45 - 3.58 per share.Directo79.68927 abr 202222.912

REESE LOU
Officer and Director

Purchase at price 3.37 per share.Indirecto27.07325 abr 20228.038

HU MEI MEI
Chief Executive Officer

Purchase at price 3.37 per share.Indirecto27.07325 abr 20228.038

UNITED BIOMEDICAL, INC.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 3.37 per share.Directo27.07325 abr 20228.038

DIAMANDIS PETER
Director

Conversion of Exercise of derivative security at price 4.12 per share.Directo2.688.86524 ene 2022652.764

DIAMANDIS PETER
Director

Conversion of Exercise of derivative security at price 4.12 per share.Directo2.688.86524 ene 2022652.764

CHUI JAMES
Director

Purchase at price 5.48 per share.Directo32.88031 dic 20216.000

CHUI JAMES
Director

Purchase at price 7.89 per share.Directo63.12010 dic 20218.000

DIAMANDIS PETER
Director

Sale at price 13.00 per share.Directo3.22418 nov 2021248

BLATT GREGORY R
Director

Purchase at price 13.50 per share.Indirecto1.038.46015 nov 202176.923

BLATT GREGORY R
Director

Indirecto15 nov 2021836.737

DIAMANDIS PETER
Director

Purchase at price 13.50 per share.Indirecto1.038.46015 nov 202176.923

DIAMANDIS PETER
Director

Indirecto15 nov 2021271.655

DIAMANDIS PETER
Director

Purchase at price 16.00 per share.Indirecto1.230.76815 nov 202176.923

DIAMANDIS PETER
Director

Indirecto15 nov 202127.648

PRIME MOVERS LAB LLC
Beneficial Owner of more than 10% of a Class of Security

Indirecto15 nov 202118.027.314

PALM ULO
Officer

Purchase at price 13.00 per share.Indirecto5.85015 nov 2021450

REESE LOU
Officer and Director

Indirecto15 nov 20214.731.200

HU MEI MEI
Chief Executive Officer

Indirecto15 nov 20214.731.200

UNITED BIOMEDICAL, INC.
Beneficial Owner of more than 10% of a Class of Security

Indirecto15 nov 20214.459.545

PRIME MOVERS LAB FUND I LP
Beneficial Owner of more than 10% of a Class of Security

Indirecto15 nov 202118.027.314

REESE LOU
Officer and Director

Purchase at price 13.82 per share.Directo241.92012 nov 202117.500

HU MEI MEI
Chief Executive Officer

Purchase at price 13.82 per share.Indirecto241.92012 nov 202117.500